EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting extracellular matrix mechanobiology to suppress solid tumor progression

Keefer Boone, Raghu Vamsi Kondapaneni, Sarah Libring, Cynthia A Reinhart-King

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218856 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026. Verfasst von Keefer Boone und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Rice University, Houston, TX, 77030, USA. Electronic address: kb125@rice.edu. Hauptthemen laut MEDLINE: Extracellular Matrix, Neoplasms, Mechanotransduction, Cellular, Antineoplastic Agents. Die Arbeit nennt 285 Literaturangaben. Gefördert von: National Institutes of Health, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid tumor progression is associated with several mechanical changes, including compression inside the tumor and stiffening and tension at the tumor edge and in the tumor-adjacent stroma. Mechanical remodeling of the extracellular matrix is an active driver of therapeutic resistance and metastatic potential. As such, the field of mechanobiology has increasingly investigated the clinical targeting of stromal mechanics and the mechanotransduction signaling pathways activated by such stromal aberrations. Here, we review therapeutic strategies that target tumor mechanics, organized into therapies that target the matrix composition and therapies that target the downstream cellular machinery through which mechanical signals are transduced into malignant behavior. We emphasize active and past clinical trials wherever possible, recognizing that the distance between preclinical promise and clinical reality remains a central challenge in medicine. Together, these approaches highlight emerging opportunities and persistent challenges in therapeutically targeting tumor mechanics alongside traditional therapies to improve clinical cancer outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular MatrixNeoplasmsMechanotransduction, CellularAntineoplastic AgentsHumansAnimalsDisease ProgressionMolecular Targeted TherapyTumor Microenvironment

Stichwörter der Autor:innen

Clinical trialsExtracellular matrixMatrix crosslinkingMatrix stiffeningMechanobiologyMechanotransductionStromal mechanics

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Bioengineering, Rice University, Houston, TX, 77030, USA. Electronic address: kb125@rice.edu.
  • Department of Bioengineering, Rice University, Houston, TX, 77030, USA. Electronic address: rk122@rice.edu.
  • Department of Bioengineering, Rice University, Houston, TX, 77030, USA. Electronic address: sl278@rice.edu.
  • Department of Bioengineering, Rice University, Houston, TX, 77030, USA. Electronic address: cr73@rice.edu.

Förderung

  • National Institutes of Health
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Boone, K., Kondapaneni, R. V., Libring, S., & Reinhart-King, C. A. (2026). Targeting extracellular matrix mechanobiology to suppress solid tumor progression. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218856

Vancouver

Boone K, Kondapaneni RV, Libring S, Reinhart-King CA. Targeting extracellular matrix mechanobiology to suppress solid tumor progression. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218856

BibTeX
@article{Boone2026,
  author = {Boone, Keefer and Kondapaneni, Raghu Vamsi and Libring, Sarah and Reinhart-King, Cynthia A},
  title = {Targeting extracellular matrix mechanobiology to suppress solid tumor progression},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218856}
}
Kostenlos starten →